Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers

Clinical trial NCT01153997 · COMPLETED

Trial details

NCT number: NCT01153997
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Cardiac Surgery Requiring Cardiopulmonary Bypass Healthy

Start date: 2010-06-01
Primary completion: 2010-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.